Our Clinical Advisors

Richard Hindley is a Consultant Urologist at Hampshire Hospitals and was appointed in 2014. In 2017 he was awarded a visiting Professor position working with the Department of Health and Wellbeing at the University of Winchester. This was in recognition of his growing prostate research portfolio which includes collaborating with other units including UCLH and the University of Oxford. He was privileged to be involved with the PROMIS and PRECISION trials, which have changed forever the diagnostic pathway for men with suspected prostate cancer. He has publications in both the Lancet at the NEJM. His interests relate not only to prostate cancer diagnostics but also focal therapy as a treatment option for men with intermediate risk prostate cancer, as well as minimally invasive treatments for benign prostatic obstruction and men’s health issues in general. 

Professor Gordon Wishart is the founder, Chief Medical Officer and CEO of Check4Cancer, a leading early cancer detection and cancer prevention company. In 2016 Check4Cancer launched rapid access, streamlined and audited diagnostic pathways for breast and skin cancer to the insured and self-pay markets, leading to the award of “Diagnostic Provider of the Year” at the annual Health Investor Awards in 2018. In late 2017, Check4Cancer launched the first worldwide breast cancer risk test (MyBreastRisk) to combine genetic, family history and lifestyle risk factors to underpin a risk-stratified breast screening programme. As the former Director of the Cambridge Breast Unit from 2005-2010, and current Professor of Cancer Surgery at Anglia Ruskin School of Medicine since 2008, he has a strong track record in clinical research and modernisation of cancer diagnosis and treatment, with more than 100 peer-reviewed papers in scientific journals. In 2010 he led a team of clinicians and scientists that developed the PREDICT breast cancer treatment and survival model, now used worldwide.

Jullien Brady has extensive experience in the UK cervical screening program. He is a former National Quality Assurance Director for the NHS Cervical screening Program. He is currently the Professional Clinical Advisor for Colposcopy for Public Health England. He is also a member of the Executive Committee of the BSCCP, the governing body of Colposcopy. Mr Brady is passionate about women having the opportunity to maximise their health choices and screening options. Having done all his undergraduate and post graduate training in London Mr Brady was appointed as a Consultant in 2008.

Professor Andrew Beggs is a Professor of Cancer Genetics & Surgery at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust. He runs a diverse research group of scientists and clinicians studying the molecular determinants of response to cancer treatments using organoid models and next-generation sequencing models. He is also an active cancer clinician, running a familial cancer clinic for the West Midlands Region and one of the national gastrointestinal polyposis centres. Professor Beggs acts as a scientific adviser to the UK Department of Health and Social Care and Genomics England.

Professor Simon Russell is a Consultant Oncologist at Addenbrooke’s Hospital, Cambridge and Hinchingbrooke Hospital, Huntingdon. He leads the Urological Malignancy Service and has previously been lead clinician for the breast service. He is the lead for Radiotherapy for Genesis Cancer Care, Cambridge. He has served as the secretary of the British Uro-Oncology Group 2003-2015 and remains a Trustee. He was appointed Professor of Oncology at the University of Rome Medical School, Tor Vergata 2015. Simon joined Check4Cancer in 2018.

Mr Per Hall has been a consultant plastic surgeon in Cambridge since 1995. He has been a pioneer in the early detection of skin cancer using computer imaging for over 20 years. Mr Hall and his team have had a major input in the development of SIAscopy, producing the most clinical papers on the subject. He continues to collaborate in studies aiming to help identify suspicious skin lesions at the earliest opportunity and continues to work with computer scientists on ways to improve diagnosis including the use of artificial intelligence. Mr Hall is also committed to the reconstructive surgical needs of children in developing countries and regularly trains surgeons in cleft lip and palate surgery in Ethiopia to facilitate this. Mr Hall oversees the SkinCheck service.

Sam Janes is Professor of Respiratory Medicine at University College London (UCL) and Director of Respiratory Research at UCL.

He has strong research interest in improving diagnostic techniques for lung cancer. Professor Janes qualified in 1992. He leads a group interested in the pathogenesis of lung disease including cancer formation and its treatment with new biological and cellular therapies within UCL Respiratory Research Department. He has a particular interest in early diagnosis of lung cancer. In 2012, he formed the ‘Lungs for Living Research Centre’ supported by the UCLH Charitable Foundation focusing on researching early lung cancer and the role of stem cells in its formation and treatments. His important work has been recognised by a number of international awards for his research team and the personal award of European Thoracic Oncology Investigator of the Year in 2010.

Professor Janes has published around 150 papers on lung cancer in journals such as ‘Nature’, and ’Nature Medicine’ and he sits on scientific committees assessing research proposals. Professor Janes also spends time helping  CRUK, Roy Castle Lung Cancer Foundation and MacMillan with academic assessments, and public facing brochures. He is the lead of four academic randomised clinical trials and most notably recently launched the SUMMIT study, a 25,000 participant London based study examining CT and blood screening for lung and other cancers.